Early loss to follow-up of recently diagnosed HIV-infected adults from routine pre-ART care in a rural district hospital in Kenya: a cohort study

Tropical Medicine and International Health

Volumn 17, Issue 1, 2012, Pages 82-93

  Hassan, Amin S ^a   Fielding, Katherine L ^b   Thuo, Nahashon M ^a   Nabwera, Helen M ^a   Sanders, Eduard J ^a,c   Berkley, James A ^a,c  

^a KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

HIV; Lost to follow up; Pre antiretroviral therapy; Retention

Indexed keywords

ANTIRETROVIRUS AGENT; COTRIMOXAZOLE;

ADULT; BASELINE CONDITIONS; COHORT ANALYSIS; DISEASE SEVERITY; HOSPITAL SECTOR; HUMAN IMMUNODEFICIENCY VIRUS; LOGISTICS; REGRESSION ANALYSIS; RURAL AREA; SEASONALITY; SPATIOTEMPORAL ANALYSIS;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONSULTATION; CONTROLLED STUDY; DISEASE SEVERITY; EDUCATIONAL STATUS; EVIDENCE BASED MEDICINE; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KENYA; MAJOR CLINICAL STUDY; MALE; MARRIAGE; OUTCOME ASSESSMENT; PATIENT CARE; PREDICTOR VARIABLE; PROSPECTIVE STUDY; PUBLIC HOSPITAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; RURAL HEALTH CARE; SEASONAL VARIATION; SURVIVAL RATE; TREATMENT DURATION; TREATMENT REFUSAL;

ADOLESCENT; ADULT; AGED; ANTI-HIV AGENTS; EDUCATIONAL STATUS; FEMALE; FOLLOW-UP STUDIES; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HOSPITALS, DISTRICT; HOSPITALS, RURAL; HUMANS; KENYA; LOST TO FOLLOW-UP; MALE; MARITAL STATUS; MIDDLE AGED; PATIENT COMPLIANCE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; SEASONS; SOCIAL CLASS; YOUNG ADULT;

KENYA;

EID: 84155167070     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2011.02889.x     Document Type: Article

References (30)

1. Amuron B, Namara G, Birungi J et al. (2009) Mortality and loss-to-follow-up during the pre-treatment period in an antiretroviral therapy programme under normal health service conditions in Uganda. BMC Public Health 9, 290.
2. Bassett IV, Wang B, Chetty S et al. (2009) Loss to care and death before antiretroviral therapy in Durban, South Africa. Journal of Acquired Immune Deficiency Syndromes 51, 135-139.
3. Bassett IV, Regan S, Chetty S et al. (2010) Who starts antiretroviral therapy in Durban, South Africa?... not everyone who should. AIDS 24 (Suppl. 1), S37-S44.
4. Boulle A, Bock P, Osler M et al. (2008) Antiretroviral therapy and early mortality in South Africa. Bulletin of the World Health Organization 86, 678-687.
5. Brinkhof MW, Dabis F, Myer L et al. (2008) Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. Bulletin of the World Health Organization 86, 559-567.
6. Brinkhof MW, Pujades-Rodriguez M & Egger M (2009) Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PLoS One 4, e5790.
7. Chi BH, Cantrell RA, Mwango A et al. (2010) An empirical approach to defining loss to follow-up among patients enrolled in antiretroviral treatment programs. American Journal of Epidemiology 171, 924-931.
8. Etienne M, Burrows L, Osotimehin B et al. (2010) Situational analysis of varying models of adherence support and loss to follow up rates; findings from 27 treatment facilities in eight resource limited countries. Tropical Medicine and International Health 15 (Suppl. 1), 76-81.
9. Fenner L, Brinkhof MW, Keiser O et al. (2010) Early mortality and loss to follow-up in HIV-infected children starting antiretroviral therapy in Southern Africa. Journal of Acquired Immune Deficiency Syndromes 54, 524-532.
10. Fox MP & Rosen S (2010) Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa 2007-2009: systematic review. Tropical Medicine and International Health 15 (Suppl. 1), 1-15.
11. Grant AD, Charalambous S, Fielding KL et al. (2005) Effect of routine isoniazid preventive therapy on tuberculosis incidence among HIV-infected men in South Africa: a novel randomized incremental recruitment study. JAMA 293, 2719-2725.
12. Karcher H, Omondi A, Odera J, Kunz A & Harms G (2007) Risk factors for treatment denial and loss to follow-up in an antiretroviral treatment cohort in Kenya. Tropical Medicine and International Health 12, 687-694.
13. Krebs DW, Chi BH, Mulenga Y et al. (2008) Community-based follow-up for late patients enrolled in a district-wide programme for antiretroviral therapy in Lusaka, Zambia. AIDS Care 20, 311-317.
14. Larson BA, Brennan A, Mcnamara L et al. (2010) Early loss to follow up after enrolment in pre-ART care at a large public clinic in Johannesburg, South Africa. Tropical Medicine and International Health 15 (Suppl. 1), 43-47.
15. Lawn SD, Harries AD, Anglaret X, Myer L & Wood R (2008) Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS 22, 1897-1908.
16. Lessells RJ, Mutevedzi PC, Cooke GS & Newell ML (2011) Retention in HIV care for individuals not yet eligible for antiretroviral therapy: rural KwaZulu-Natal, South Africa. Journal of Acquired Immune Deficiency Syndromes 56, e79-e86.
17. Losina E, Bassett IV, Giddy J et al. (2010) The "ART" of linkage: pre-treatment loss to care after HIV diagnosis at two PEPFAR sites in Durban, South Africa. PLoS One 5, e9538.
18. Maskew M, Macphail P, Menezes C & Rubel D (2007) Lost to follow up: contributing factors and challenges in South African patients on antiretroviral therapy. South African Medical Journal 97, 853-857.
19. McGuire M, Munyenyembe T, Szumilin E et al. (2010) Vital status of pre-ART and ART patients defaulting from care in rural Malawi. Tropical Medicine and International Health 15 (Suppl. 1), 55-62.
20. Merten S, Kenter E, Mckenzie O, Musheke M, Ntalasha H & Martin-Hilber A (2010) Patient-reported barriers and drivers of adherence to antiretrovirals in sub-Saharan Africa: a meta-ethnography. Tropical Medicine and International Health 15 (Suppl. 1), 16-33.
21. Ochieng-Ooko V, Ochieng D, Sidle JE et al. (2010) Influence of gender on loss to follow-up in a large HIV treatment programme in western Kenya. Bulletin of the World Health Organization 88, 681-688.
22. Rosen S, Fox MP & Gill CJ (2007) Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med 4, e298.
23. Russell EC, Charalambous S, Pemba L, Churchyard GJ, Grant AD & Fielding K (2010) Low haemoglobin predicts early mortality among adults starting antiretroviral therapy in an HIV care programme in South Africa: a cohort study. BMC Public Health 10, 433.
24. Tassie JM, Baijal P, Vitoria MA, Alisalad A, Crowley SP & Souteyrand Y (2010) Trends in retention on antiretroviral therapy in national programs in low-income and middle-income Countries. Journal of Acquired Immune Deficiency Syndromes 54, 437-441.
25. Toure S, Kouadio B, Seyler C et al. (2008) Rapid scaling-up of antiretroviral therapy in 10, 000 adults in Cote d'Ivoire: 2-year outcomes and determinants. AIDS 22, 873-882.
26. UNAIDS 2010. UNAIDS Outlook Report. Geneva, Switzerland.
27. Walson JL, Otieno PA, Mbuchi M et al. (2008) Albendazole treatment of HIV-1 and helminth co-infection: a randomized, double-blind, placebo-controlled trial. AIDS 22, 1601-1609.
28. WHO 2006. Antiretroviral Therapy for HIV Infection in Adults and Adolescents: Recommendations for a Public Health Approach. WHO, Geneva.
29. Yiannoutsos CT, An MW, Frangakis CE et al. (2008) Sampling-based approaches to improve estimation of mortality among patient dropouts: experience from a large PEPFAR-funded program in Western Kenya. PLoS One 3, e3843.
30. Yu JK, Chen SC, Wang KY et al. (2007) True outcomes for patients on antiretroviral therapy who are "lost to follow-up" in Malawi. Bulletin of the World Health Organization 85, 550-554.